Cargando…

Virtual screen for repurposing approved and experimental drugs for candidate inhibitors of EBOLA virus infection

The ongoing Ebola virus epidemic has presented numerous challenges with respect to control and treatment because there are no approved drugs or vaccines for the Ebola virus disease (EVD). Herein is proposed simple theoretical criterion for fast virtual screening of molecular libraries for candidate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Veljkovic, Veljko, Loiseau, Philippe M., Figadere, Bruno, Glisic, Sanja, Veljkovic, Nevena, Perovic, Vladimir R., Cavanaugh, David P., Branch, Donald R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000Research 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329668/ https://www.ncbi.nlm.nih.gov/pubmed/25717373 http://dx.doi.org/10.12688/f1000research.6110.1

Ejemplares similares

In silico analysis suggests repurposing of ibuprofen for prevention and treatment of EBOLA virus disease
por: Veljkovic, Veljko, et al.
Publicado: (2015)

Virtual Screen for Repurposing of Drugs for Candidate Influenza a M2 Ion-Channel Inhibitors
por: Radosevic, Draginja, et al.
Publicado: (2019)

In silico analysis suggests interaction between Ebola virus and the extracellular matrix
por: Veljkovic, Veljko, et al.
Publicado: (2015)

Simple Chemoinformatics Criterion Using Electron Donor-Acceptor Molecular Characteristics for Selection of Antibiotics Against Multi-Drug-Resistant Bacteria
por: Veljkovic, Veljko, et al.
Publicado: (2016)

Evolution of 2014/15 H3N2 Influenza Viruses Circulating in US: Consequences for Vaccine Effectiveness and Possible New Pandemic
por: Veljkovic, Veljko, et al.
Publicado: (2015)

Identification of hemagglutinin structural domain and polymorphisms which may modulate swine H1N1 interactions with human receptor
por: Veljkovic, Veljko, et al.
Publicado: (2009)

Characterization of conserved properties of hemagglutinin of H5N1 and human influenza viruses: possible consequences for therapy and infection control
por: Veljkovic, Veljko, et al.
Publicado: (2009)

Predicted Enhanced Human Propensity of Current Avian-Like H1N1 Swine Influenza Virus from China
por: Veljkovic, Veljko, et al.
Publicado: (2016)

Novel Entropy-Based Phylogenetic Algorithm: A New Approach for Classifying SARS-CoV-2 Variants
por: Perovic, Vladimir, et al.
Publicado: (2023)

Physical Activity and Natural Anti-VIP Antibodies: Potential Role in Breast and Prostate Cancer Therapy
por: Veljkovic, Milena, et al.
Publicado: (2011)

Feature-Based Classification of Amino Acid Substitutions outside Conserved Functional Protein Domains
por: Gemovic, Branislava, et al.
Publicado: (2013)

Novel Phylogenetic Algorithm to Monitor Human Tropism in Egyptian H5N1-HPAIV Reveals Evolution toward Efficient Human-to-Human Transmission
por: Perovic, Vladimir R., et al.
Publicado: (2013)

A simple method for calculation of basic molecular properties of nutrients and their use as a criterion for a healthy diet
por: Veljkovic, Veljko, et al.
Publicado: (2017)

Identification of SARS‐CoV‐2 Papain‐like Protease (PLpro) Inhibitors Using Combined Computational Approach
por: Sencanski, Milan, et al.
Publicado: (2022)

Possible repurposing of seasonal influenza vaccine for prevention of Zika virus infection
por: Veljkovic, Veljko, et al.
Publicado: (2016)

Inhibition of in vitro Ebola infection by anti-parasitic quinoline derivatives
por: Goyal, Shawn, et al.
Publicado: (2020)

Evolution of SARS-CoV-2 virus and assessment of the effectiveness of COVID-19 vaccine
por: Veljkovic, Veljko, et al.
Publicado: (2021)

Demonstration of a Direct Interaction between β(2)-Adrenergic Receptor and Insulin Receptor by BRET and Bioinformatics
por: Mandić, Maja, et al.
Publicado: (2014)

Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel In Silico Method
por: Sencanski, Milan, et al.
Publicado: (2020)

Alignment-free method for functional annotation of amino acid substitutions: Application on epigenetic factors involved in hematologic malignancies
por: Gemović, Branislava, et al.
Publicado: (2021)

Computational design and characterization of nanobody-derived peptides that stabilize the active conformation of the β(2)-adrenergic receptor (β(2)-AR)
por: Sencanski, Milan, et al.
Publicado: (2019)

Identification of Candidate Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor Which May Improve Vagus Nerve Stimulation in Chronic Tinnitus
por: Bojić, Tijana, et al.
Publicado: (2017)

The Potential of 2-Substituted Quinolines as Antileishmanial Drug Candidates
por: Loiseau, Philippe M., et al.
Publicado: (2022)

Using electronic biology based platform to predict flu vaccine efficacy for 2018/2019
por: Paessler, Slobodan, et al.
Publicado: (2018)

Prediction of influenza vaccine effectiveness for the influenza season 2017/18 in the US
por: Paessler, Slobodan, et al.
Publicado: (2017)

IDPpi: Protein-Protein Interaction Analyses of Human Intrinsically Disordered Proteins
por: Perovic, Vladimir, et al.
Publicado: (2018)

In Silico Screening of Natural Compounds for Candidates 5HT6 Receptor Antagonists against Alzheimer’s Disease
por: Bojić, Tijana, et al.
Publicado: (2022)

The first insight into the genetic structure of the population of modern Serbia
por: Drljaca, Tamara, et al.
Publicado: (2021)

In silico Therapeutics for Neurogenic Hypertension and Vasovagal Syncope
por: Bojić, Tijana, et al.
Publicado: (2016)

Repurposing of approved cardiovascular drugs
por: Ishida, Junichi, et al.
Publicado: (2016)

Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease
por: Kandeel, Mahmoud, et al.
Publicado: (2020)

Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs
por: Kouznetsova, Jennifer, et al.
Publicado: (2014)

Common molecular mechanism of the hepatic lesion and the cardiac parasympathetic regulation in chronic hepatitis C infection: a critical role for the muscarinic receptor type 3
por: Glišić, Sanja, et al.
Publicado: (2016)

Repurposing approved drugs for cancer therapy
por: Schein, Catherine H
Publicado: (2021)

FDA Approved Drugs Repurposing of Toll-Like Receptor4 (TLR4) Candidate for Neuropathy
por: Zali, Hakimeh, et al.
Publicado: (2019)

Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target
por: Veljkovic, Veljko, et al.
Publicado: (2021)

Computational Insights and Virtual Screening of Repurposed FDA-Approved Drug Against SARS-CoV-2 Protease
por: Joel, C., et al.
Publicado: (2023)

Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer’s Disease
por: Shityakov, Sergey, et al.
Publicado: (2021)

How aromatic system size affects the sensitivities of highly energetic molecules?
por: Veljković, Ivana S., et al.
Publicado: (2021)

In Silico and In Vitro Inhibition of SARS-CoV-2 PL(pro) with Gramicidin D
por: Protić, Sara, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cn34ubp4649iag6ps29sctjh0b